Moderna
MRNA
#1394
Rank
S$17.46 B
Marketcap
$45.39
Share price
-3.92%
Change (1 day)
-66.23%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of September 2024 : S$16.10 Billion

According to Moderna 's latest financial reports the company has S$16.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$18.29 B-28.63%
2022-12-31$S$25.63 B34.06%
2021-12-31$S$19.12 B464.42%
2020-12-31$S$3.38 B113.91%
2019-12-31$S$1.58 B-24.24%
2018-12-31$S$2.09 B149.96%
2017-12-31$S$0.83 B-31.36%
2016-12-31$S$1.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$0.11 B-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
S$60.18 B 273.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$49.16 Million-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$43.69 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$58.67 B 264.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$0.25 B-98.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$94.75 B 488.23%๐Ÿ‡บ๐Ÿ‡ธ USA